Literature DB >> 10702287

Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP.

A K Ghosh1, M Majumder, R Steele, P Yaciuk, J Chrivia, R Ray, R B Ray.   

Abstract

Hepatitis C virus NS5A protein transcriptionally modulates cellular genes and promotes cell growth. NS5A is likely to exert its activity in concert with cellular factor(s). Using a yeast two-hybrid screen, we have demonstrated that NS5A interacts with the C-terminal end of a newly identified cellular transcription factor, SRCAP. The authenticity of this interaction was verified by a mammalian two-hybrid assay, in vitro pull-down experiment, and an in vivo coimmunoprecipitation assay in human hepatoma (HepG2) cells. An in vitro transient transfection assay demonstrated that SRCAP can efficiently activate transcription when recruited by the Gal4 DNA-binding domain to the promoter. However, down-regulation of p21 promoter activity by NS5A was enhanced following ectopic expression of SRCAP. Together these results suggest that the interaction of NS5A and SRCAP may be one of the mechanisms by which NS5A exerts its effect on cell growth regulation contributing to hepatitis C virus-mediated pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702287     DOI: 10.1074/jbc.275.10.7184

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  A novel 16-kilodalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1.

Authors:  A K Ghosh; M Majumder; R Steele; R A White; R B Ray
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 2.  Structure and functions of hepatitis C virus proteins: 15 years after.

Authors:  L Krekulová; V Rehák; L W Riley
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

3.  TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.

Authors:  D G Cordek; J T Bechtel; A T Maynard; W M Kazmierski; C E Cameron
Journal:  Drugs Future       Date:  2011-09       Impact factor: 0.148

4.  The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A.

Authors:  Helen Waller; Udayan Chatterji; Philippe Gallay; Tanya Parkinson; Paul Targett-Adams
Journal:  J Virol Methods       Date:  2010-02-02       Impact factor: 2.014

5.  Cloning and identification of NS5ATP2 gene and its spliced variant transactivated by hepatitis C virus non-structural protein 5A.

Authors:  Qian Yang; Jun Cheng; Yan Liu; Yuan Hong; Jian-Jun Wang; Shu-Lin Zhang
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

6.  Efficient rescue of hepatitis C virus RNA replication by trans-complementation with nonstructural protein 5A.

Authors:  Nicole Appel; Ulrike Herian; Ralf Bartenschlager
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

7.  Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1.

Authors:  Ishtiaq Qadri; Mieko Iwahashi; Juan M Capasso; Matthew W Hopken; Sonia Flores; Jerome Schaack; Francis R Simon
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

8.  Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon.

Authors:  Tetsuro Shimakami; Makoto Hijikata; Hong Luo; Yuan Yuan Ma; Shuichi Kaneko; Kunitada Shimotohno; Seishi Murakami
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding.

Authors:  Guo-Zhong Gong; Yong-Fang Jiang; Yan He; Li-Ying Lai; Ying-Hua Zhu; Xian-Shi Su
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

10.  Calcium-dependent calpain proteases are implicated in processing of the hepatitis C virus NS5A protein.

Authors:  M Kalamvoki; P Mavromara
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.